Federal award
SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH
W81XWH1810461
Assistance
Obligated and Ceiling
- Obligated (net)
- $1,069,689.40
- Potential value
- —
- Current value
- —
- Gross positive obligations
- $1,072,013.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH · DRRKVZVXSND3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH · DRRKVZVXSND3
- Awarding agency
- Department of Defense · sub-agency 97DH · office HT9425
- Funding agency
- Department of Defense · sub-agency 97DH
- Assistance listing (CFDA)
- CFDA 12.420
- FAIN
- W81XWH1810461
- Award type code
- 04
- Actions
- 5 · Jul 19, 2018 to Jan 16, 2025
- Why it is listed
- a program on the reviewed research-assistance allowlist (DoD, DOE or NASA from $10k, or eligible DHS research)
Action History5
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jan 16, 2025 | FY2025 | P00004 | FX | −$2,323.60 | — |
| May 24, 2023 | FY2023 | P00003 | B1 | $0.00 | — |
| Jul 21, 2022 | FY2022 | P00002 | B1 | $0.00 | — |
| Aug 3, 2021 | FY2021 | P00001 | EX | $159,900.00 | — |
| Jul 19, 2018 | FY2018 | 0 | A1 | $912,113.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.